Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells

Biochemical Journal

Volumn 366, Issue 3, 2002, Pages 729-736

  Manin, Michèle ^a   Baron, Silvère ^a   Goossens, Karine ^a   Beaudoin, Claude ^a   Jean, Claude ^a   Veyssiere, Georges ^a   Verhoeven, Guido ^a   Morel, Laurent ^a  

^a CNRS   (France)

Author keywords

Androgens and growth factor signalling; Cell differentiation; Epithelial cells

Indexed keywords

ENZYME INHIBITION; GENES; PATHOLOGY; SIGNALING; TUMORS;

RECEPTOR EXPRESSIONS;

BIOCHEMISTRY;

ANDROGEN RECEPTOR; ANDROSTANOLONE; LIGAND; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; RECEPTOR UPREGULATION; VAS DEFERENS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANDROGEN; RNA; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037106457     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020585     Document Type: Article

References (38)

1. Cunha, G. R., Alarid, E. T., Turner, T., Donjacour, A. A., Boutin, E. L. and Foster, B. A. (1992) Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal -epithelial interactions, and growth factors. J. Androl. 13, 465-475
2. El-Alfy, M., Luu-The, V., Huang, X. F., Berger, L., Labrie, F. and Pelletier, G. (1999) Localization of type 5 17β-hydroxysteroid dehydrogenase, 3β-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology (Baltimore) 140, 1481-1491
3. Isaacs, J. T. (1994) Role of androgens in prostatic cancer. Vitam. Horm. (N.Y.) 49, 433-502
4. Garnick, M. B. (1993) Prostate cancer: screening, diagnosis, and management. Ann. Intern. Med. 118, 804-818
5. van der Kwast, T. H., Schalken, J., Ruizeveld de Winter, J. A., van Vroonhoven, C. C., Mulder, E, Boersma, W. and Trapman, J. (1991) Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int. J. Cancer 48, 189-193
6. Culig, Z., Hobisch, A., Hittmair, A., Peterziel, H., Cato, A. C., Bartsch, G. and Docker, H. (1998) Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate 35, 63-70
7. Taplin, M. E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N. and Balk, S. P. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med. 332, 1393-1398
8. Kolibaba, K. S. and Druker, B. J. (1997) Protein tyrosine kinases and cancer. Biochim. Biophys. Acta 1333, F217-F248
9. Agarwal, R. (2000) Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharmacol. 60, 1051-1059
10. Wainstein, M. A., He, F., Robinson, D., Kung, H. J., Schwartz, S., Giaconia, J. M., Edgehouse, N. L., Pretlow, T. P., Bodner, D. R., Kursh, E. D. et al. (1994) CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res. 54. 6049-6052
11. Manin, M., Martinez, A., Van Der Schueren, B., Reynaert, I. and Jean, C. (2000) Acquisition of androgen-mediated expression of mouse vas deferens protein (MVDP) gene in cultured epithelial cells and in vas deferens during postnatal development. J. Androl. 21, 641-650
12. Manin, M., Veyssiere, G., Cheyvialle, D., Chevalier, M., Lecher, P. and Jean, C. (1992) In vitro androgenic induction of a major protein in epithelial cell subcultures from mouse vas deferens. Endocrinology (Baltimore) 131, 2378-2386
13. Lobaccaro, J. M., Poujol, N., Terouanne, B., Georget, V., Fabre, S., Lumbroso, S. and Sultan, C. (1999) Transcriptional interferences between normal or mutant androgen receptors and the activator protein 1 - dissection of the androgen receptor functional domains. Endocrinology (Baltimore) 140, 350-357
14. Songyang, Z., Baltimore, D., Cantley, L. C., Kaplan, D. R. and Franke, T. F. (1997) Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. U.S.A. 94, 11345-11350
15. Marivoet, S., Hertogen, M., Verhoeven, G. and Heyns, W. (1990) Antibodies against synthetic peptides recognize the human and rat androgen receptor. J. Steroid Biochem. Mol. Biol. 37, 39-45
16. Kemppainen, J. A., Lane, M. V., Sar, M. and Wilson, E. M. (1992) Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J. Biol. Chem. 267, 968-974
17. Adamo, M., Roberts, Jr, C. T. and LeRoith, D. (1992) How distinct are the insulin and insulin-like growth factor I signalling systems? Biofactors 3, 151-157
18. Vlahos, C. J., Matter, W. F., Hui, K. Y. and Brown, R. F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248
19. Sanchez-Margalet, V., Goldfine, I. D., Vlahos, C. J. and Sung, C. K. (1994) Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002. Biochem. Biophys Res. Commun. 204, 446-452
20. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G. and Klocker, H. (1994) Androgen-receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54, 5474-5478
21. Dai, J. L., Maiorino, C. A., Gkonos, P. J. and Burnstein, K. L. (1996) Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Steroids 61, 531-539
22. Russell, P. J., Bennett, S. and Stricker, P. (1998) Growth factor involvement in progression of prostate cancer. Clin. Chem. 44, 705-723
23. Gingras, A. C., Kennedy, S. G., O'Leary, M. A., Sonenberg, N. and Hay, N. (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 12, 502-513
24. Nave, B. T., Ouwens, M., Withers, D. J., Alessi, D. R. and Shepherd, P. R. (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344, 427-431
25. Weigel, N. L. (1996) Steroid hormone receptors and their regulation by phosphorylation. Biochem. J. 319, 657-667
26. Yeh, S., Lin, H. K., Kang, H. Y., Thin, T. H., Lin, M. F. and Chang, C. (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 96, 5458-5463
27. Du, K. and Montminy, M. (1998) CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273, 32377-32379
28. Kane, L. P., Shapiro, V. S., Stokoe, D. and Weiss, A. (1999) Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9, 601-604
29. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868
30. Pekarsky, Y. Hallas, C., Palamarchuk, A., Koval, A., Bullrich, F., Hirata, Y., Bichi, R., Letofsky, J. and Croce, C. M. (2001) Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc. Natl. Acad. Sci. U.S.A. 98, 3690-3694
31. Altiok, S., Batt, D., Altiok, N., Papautsky, A., Downward, J., Roberts, T. M. and Avraham, H. (1999) Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-kinase/AKT in breast cancer cells. J. Biol. Chem. 274, 32274-32278
32. Lin, J., Adam, R. M., Santiestevan, E. and Freeman, M. R. (1999) The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res. 59, 2891-2897
33. Wen, Y., Hu, M. C., Makino, K., Spohn, B., Bartholomeusz, G., Yah, D. H. and Hung, M. C. (2000) HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 60, 6841-6845
34. Daduang, S., Kimura, K., Nagata, S. and Fukui, Y. (1998) Density dependent elevation of phosphatidylinositol-3 kinase level in rat 3Y1 cells. Biochim. Biophys. Acta 1401, 113-120
35. Farrelly, N., Lee, Y. J., Oliver, J., Dive, C. and Streuli, C. H. (1999) Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J. Cell. Biol. 144, 1337-1348
36. Gilmore, A. P., Metcalfe, A. D., Romer, L. H. and Streuli, C. H. (2000) Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J. Cell Biol. 149, 431-446
37. Ueki, K., Yamamoto-Honda, R., Kaburagi, Y., Yamauchi, T., Tobe, K., Burgering, B. M., Coffer, P. J., Komuro, I., Akanuma, Y., Yazaki, Y. and Kadowaki, T. (1998) Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273, 5315-5322
38. Vlietstra, R. J., van Alewijk, D. C., Hermans, K. G., van Steenbrugge, G. J. and Trapman, J. (1998) Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancel Res. 58, 2720-2723